Literature DB >> 19823872

Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices.

Sebastian Di Cesare1, Andre Nantel, Jean-Claude Marshall, Bruno F Fernandes, Emilia Antecka, Maria E Orellana, Daniel Abourbih, Antonia M Saornil, Miguel N Burnier.   

Abstract

PURPOSE: Fresh biopsied ocular tumor tissues are difficult to obtain for the purpose of performing microarray experiments on extracted nucleic acids. Present technology allows for extraction of total RNA from formalin-fixed paraffin embedded (FFPE) tissue analyzed by the cDNA mediated Annealing Sectioning and Ligation (DASL) method. We aimed to correlate gene transcript differences between two uveal melanoma (UM) clinical-histopathological parameters (metastasis, cell type).
METHODS: A total of 43 FFPE UM were used. The expression of RPL13a, a ribosomal protein gene, for each sample was used to evaluate the quality of RNA extracted from FFPE tissue. Gene expression values generated from the array were analyzed using the GeneSpring GX software (Agilent). Immunohistochemistry was used in order to validate transcriptional findings at the protein level.
RESULTS: A total of 106 genes were identified with (P < 0.05, Welch ANOVA test) a difference in transcript abundance for the metastasis clinical parameter. Furthermore, we identified 64 genes with a statistically significant (P < 0.05) difference in transcript abundance between the spindle and epithelioid cell types. Each individual sample for both groups (metastasis, cell type) exhibited distinct transcriptional profiles that were separated on a PCA. Positive nuclear immunostaining for LIG4-metastasis, ErbB3-cell type was found to be associated with better patient prognosis and outcome.
CONCLUSIONS: To the best of our knowledge, this is the first time that a successful retrospective analysis has been done with UM FFPE RNA. This data may lead to future customized therapeutic targets, which may improve the now unchanged mortality rate of this particular malignancy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19823872     DOI: 10.1007/s00432-009-0692-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

1.  Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue.

Authors:  T Ekberg; M Nestor; M Engström; H Nordgren; K Wester; J Carlsson; M Anniko
Journal:  Int J Oncol       Date:  2005-05       Impact factor: 5.650

2.  Correlation of comparative genomic hybridization results of 100 archival uveal melanomas with patient survival.

Authors:  Jason S White; Ian W McLean; Robert L Becker; Alison E Director-Myska; Joginder Nath
Journal:  Cancer Genet Cytogenet       Date:  2006-10-01

3.  Immunohistochemical expression of phospho-Akt in uveal melanoma.

Authors:  Vinicius S Saraiva; Amanda L Caissie; Laura Segal; Chaim Edelstein; Miguel N Burnier
Journal:  Melanoma Res       Date:  2005-08       Impact factor: 3.599

4.  Reduced expression of autotaxin predicts survival in uveal melanoma.

Authors:  Arun D Singh; Karen Sisley; Yaomin Xu; Jianbo Li; Pieter Faber; Sarah J Plummer; Hardeep S Mudhar; Ian G Rennie; Patricia M Kessler; Graham Casey; Bryan G Williams
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

5.  Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development.

Authors:  Pieter A van der Velden; Wieke Zuidervaart; Monique H M H Hurks; Sandra Pavey; Bruce R Ksander; Elise Krijgsman; Rune R Frants; Cornelis P Tensen; Rein Willemze; Martine J Jager; Nelleke A Gruis
Journal:  Int J Cancer       Date:  2003-09-10       Impact factor: 7.396

6.  Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.

Authors:  Hanneke W Mensink; Emine Kiliç; Jolanda Vaarwater; Hannie Douben; Dion Paridaens; Annelies de Klein
Journal:  Cancer Genet Cytogenet       Date:  2008-03

7.  HER3 is a determinant for poor prognosis in melanoma.

Authors:  Markus Reschke; Daniela Mihic-Probst; Edward Htun van der Horst; Pjotr Knyazev; Peter J Wild; Markus Hutterer; Stefanie Meyer; Reinhard Dummer; Holger Moch; Axel Ullrich
Journal:  Clin Cancer Res       Date:  2008-08-15       Impact factor: 12.531

8.  A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988.

Authors:  M Diener-West; B S Hawkins; J A Markowitz; A P Schachat
Journal:  Arch Ophthalmol       Date:  1992-02

9.  Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.

Authors:  Walter van Gils; Emine Kilic; Hennie T Brüggenwirth; Jolanda Vaarwater; Michael M Verbiest; Berna Beverloo; Marjan E van Til-Berg; Dion Paridaens; Gregorius P Luyten; Annelies de Klein
Journal:  Melanoma Res       Date:  2008-02       Impact factor: 3.599

10.  Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma.

Authors:  Michael D Onken; Lori A Worley; Erica Person; Devron H Char; Anne M Bowcock; J William Harbour
Journal:  Clin Cancer Res       Date:  2007-05-15       Impact factor: 12.531

View more
  1 in total

1.  Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples.

Authors:  J S Hall; H S Leong; L S C Armenoult; G E Newton; H R Valentine; J J Irlam; C Möller-Levet; K A Sikand; S D Pepper; C J Miller; C M L West
Journal:  Br J Cancer       Date:  2011-03-15       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.